Logo image
Recurrent Atypical Hemolytic Uremic Syndrome in Children With Acute Lymphoblastic Leukemia Undergoing Maintenance Chemotherapy
Journal article   Peer reviewed

Recurrent Atypical Hemolytic Uremic Syndrome in Children With Acute Lymphoblastic Leukemia Undergoing Maintenance Chemotherapy

Geoffrey Cheng, Bulent Ozgonenel, Kanta Bhambhani, Gaurav Kapur, Richard J Smith and Süreyya Savaşan
Journal of pediatric hematology/oncology, Vol.40(7), pp.560-562
10/2018
DOI: 10.1097/MPH.0000000000000987
PMID: 28991131

View Online

Abstract

Chemotherapy-associated myelosuppression and renal dysfunction is not uncommon during childhood acute lymphoblastic leukemia (ALL) therapy. Here we report 2 cases of atypical hemolytic uremic syndrome (aHUS) presenting with pancytopenia and renal dysfunction that developed during maintenance chemotherapy characterized by hypocomplementemia. Both cases experienced recurrence after resolution of the initial aHUS episode upon resumption of chemotherapy, raising a possible contributory role for chemotherapy in the disease pathogenesis.
Maintenance Chemotherapy - adverse effects Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Recurrence Pancytopenia - chemically induced Maintenance Chemotherapy - methods Antineoplastic Agents - adverse effects Atypical Hemolytic Uremic Syndrome - chemically induced Humans Kidney Diseases - chemically induced Child

Details

Metrics

Logo image